CDKN1A and breast carcinoma: Although the mechanism by which NUPR1 promotes oncogenesis and/or drug resistance in pancreatic cells is not yet known, NUPR1 has been shown to form a complex with p300 and TP53 to upregulate and promote cytoplasmic translocation of CDKN1A (p21) in breast cancer cells [42].